{
    "2020-06-10": [
        [
            {
                "time": "2018-01-02",
                "original_text": "This Biotech Just Hit Pay Dirt On A Potential $3 Billion Deal With AbbVie",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Pay Dirt",
                        "$3 Billion Deal",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original",
                "features": {
                    "keywords": [
                        "Humira",
                        "Rheumatoid Arthritis",
                        "Better Treatment"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dividend Stock",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Wednesday Morning Market Highlights",
                "features": {
                    "keywords": [
                        "Market Highlights"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market analysis"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Signs $3.9 Billion Oncology Deal with Genmab",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "$3.9 Billion",
                        "Oncology Deal",
                        "Genmab"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "oncology",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Can Withstand Humiraâ€™s Decline With New Drugs",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "New Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "drug development"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie and Genmab Ink $4 Billion Cancer-Treatment Pact",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Genmab",
                        "$4 Billion",
                        "Cancer-Treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "oncology",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "ESG Investing Trend to Stay Strong Post Pandemic: 5 Top Picks",
                "features": {
                    "keywords": [
                        "ESG Investing",
                        "Post Pandemic",
                        "Top Picks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "ESG",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "Antibody Drug Conjugate",
                        "ABBV-3373",
                        "Phase 2a Study",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Genmab Shares Rise 5% In Pre-Market On Oncology Partnership With AbbVie",
                "features": {
                    "keywords": [
                        "Genmab",
                        "Shares Rise",
                        "Pre-Market",
                        "Oncology Partnership",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Genmab stock surges after drug development deal with AbbView valued at up to nearly $4 billion",
                "features": {
                    "keywords": [
                        "Genmab",
                        "stock surges",
                        "drug development deal",
                        "AbbVie",
                        "$4 billion"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie and Genmab Announce Broad Oncology Collaboration",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Genmab",
                        "Broad Oncology Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "oncology",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}